Targeting breast tumor extracellular matrix and stroma utilizing nanoparticles.

Area of Science:

• Oncology
• Nanotechnology
• Biomedical Engineering

Background:

• Breast cancer is a prevalent malignancy in women, influenced significantly by its tumor stroma and extracellular matrix (ECM).
• The ECM, composed of proteins and proteoglycans, provides structural support but can impede drug penetration into the tumor.
• Stromal components like cancer-associated fibroblasts (CAFs) and immune cells critically affect tumor progression and treatment resistance.

Purpose of the Study:

• To review recent advancements in nanoparticle-based therapies for targeting the breast tumor stroma and ECM.
• To explore how nanoparticles can enhance the delivery of anticancer drugs, including chemotherapy and small molecule drugs.
• To investigate the role of nanoparticles in modulating stromal elements like CAFs and immune cells, and in remodeling the ECM.

Main Methods:

• Literature review of nanoparticle applications in breast cancer therapy.
• Analysis of nanoparticle properties relevant to tumor stroma penetration and drug delivery.
• Examination of studies on nanoparticle-mediated reprogramming of CAFs and immune cells.

Main Results:

• Nanoparticles demonstrate improved permeability and retention in tumor stroma, enhancing drug delivery.
• Targeted nanoparticle delivery can overcome ECM barriers, increasing drug efficacy.
• Nanoparticles show potential in altering stromal components to enhance therapeutic responses.

Conclusions:

• Nanotechnology presents a promising strategy for overcoming challenges associated with the breast tumor microenvironment.
• Targeted nanoparticle delivery and stromal modulation offer novel therapeutic avenues for breast cancer treatment.
• Further research into nanoparticle-ECM and nanoparticle-stromal cell interactions is crucial for clinical translation.